This indicates that G-CSF promotes the expansion of hepatocellular carcinoma cells and their angiogenic capabilities by repressing SHP2 function within the tumor-associated macrophages, which in turn triggers the PI3K/AKT/mTOR signaling pathway. The gene discussed is MTOR; the disease is hepatocellular carcinoma.